"It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply - PubMed (original) (raw)

doi: 10.1186/s12954-022-00659-9.

Kate LaForge 2, Erin Stack 2, Justine Pope 2, Gillian Leichtling 2, Jessica E Larsen 3, Judith M Leahy 4, Andrew Seaman 3 5 6, Daniel Hoover 3, Laura Chisholm 7, Christopher Blazes 3, Robin Baker 8, Mikaela Byers 9, Katie Branson 7, P Todd Korthuis 3 8

Affiliations

"It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply

Sarah S Shin et al. Harm Reduct J. 2022.

Abstract

Background: Illicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA. For this study, we explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce overdose risk within the context of illicit fentanyl's dramatic increase in the recreational drug supply over the past decade.

Methods: We conducted in-depth interviews by phone with 34 PWUD in Oregon from May to June of 2021. We used thematic analysis to analyze transcripts and construct themes.

Results: PWUD knew about fentanyl, expressed concern about fentanyl pills, and were aware of other illicit drugs containing fentanyl. Participants were aware of the increased risk of an overdose but remained reluctant to engage with professional first responders due to fear of arrest. Participants had recommendations for reducing fentanyl overdose risk, including increasing access to information, harm reduction supplies (e.g., naloxone, fentanyl test strips), and medications for opioid use disorder; establishing drug checking services and overdose prevention sites; legalizing and regulating the drug supply; and reducing stigma enacted by healthcare providers.

Conclusion: PWUD in Oregon are aware of the rise of fentanyl and fentanyl pills and desire access to tools to reduce harm from fentanyl. As states in the Western USA face an inflection point of fentanyl in the drug supply, public health staff, behavioral health providers, and first responders can take action identified by the needs of PWUD.

Keywords: Drug supply; EMS; Fentanyl; Law enforcement; Opioids; Overdose; People who use drugs; Qualitative; Substance use.

© 2022. The Author(s).

PubMed Disclaimer

Conflict of interest statement

Andrew Seaman has received investigator-initiated research support from Gilead and Merck Pharmaceuticals.

Similar articles

Cited by

References

    1. O’Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured Fentanyls—United States, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70(50):1740–6. - PMC - PubMed
    1. Pergolizzi J, Magnusson P, LeQuang JAK, Breve F. Illicitly manufactured fentanyl entering the United States. Cureus. 2021;13:e17496. - PMC - PubMed
    1. Oregon-Idaho High Intensity Drug Trafficking Area: Oregon-Idaho HIDTA 2022 Drug Threat Assessment. 2021.
    1. Oregon Health Authority: Opioid overdose in Oregon: Report to the Legislature. Portland, OR; 2021.
    1. Shover CL, Falasinnu TO, Dwyer CL, Santos NB, Cunningham NJ, Freedman RB, Vest NA, Humphreys K. Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance. Drug Alcohol Depend. 2020;216:108314. doi: 10.1016/j.drugalcdep.2020.108314. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources